Drug Profile
UD 009
Alternative Names: UD-009Latest Information Update: 03 Oct 2023
Price :
$50
*
At a glance
- Originator Ube Industries
- Class Anti-inflammatories; Antifibrotics; Small molecules
- Mechanism of Action Lysophosphatidic acid receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Non-alcoholic steatohepatitis
Most Recent Events
- 03 Oct 2023 Discontinued - Preclinical for Non-alcoholic steatohepatitis in Japan (PO)
- 28 Dec 2020 No recent reports of development identified for preclinical development in Non-alcoholic-steatohepatitis in Japan (PO)